Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis

Mourad Tayebi, Monique David, Clive Bate, Daryl Jones, William Taylor, Rebecca Morton, John Pollard, Simon Hawke

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

The mechanisms of neuronal degeneration induced by the transformation of normal cellular prion protein (PrPC) into disease-associated PrP Sc are not fully understood. Previous reports have demonstrated that cross-linking cellular prion protein by anti-PrPC antibodies can promote neuronal apoptosis. In this report, we now show that treatment of neuronal cells with anti-prion antibodies leads to sequestration of free cholesterol in cell membranes, significant overexpression of apolipoprotein E, and to cytoplasmic phospholipase A2 activation as well as to production of prostaglandin. These results confirm the in vivo toxic effects and indicate that anti-prion antibody treatment of neurons lead to deleterious effects. Finally, great caution should be exerted when adopting antibody-based therapy for prion diseases.

Original languageEnglish
Pages (from-to)3105-3115
Number of pages11
JournalJournal of General Virology
Volume91
Issue number12
DOIs
Publication statusPublished - Dec 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis'. Together they form a unique fingerprint.

Cite this